IP Library › Assignment 023105/0880
Patent Assignment
Reel/Frame 023105/0880

Assignment of Assignor's Interest

Recorded: 2009-08-17 Pages: 2
Assignors
WANG, BING
Executed: 2009-08-04
CHU, DANIEL
Executed: 2009-08-06
Assignee
LEAD THERAPEUTICS, INC.
999 BAYHILL DRIVE, SUITE 130, SAN BRUNO, CALIFORNIA, 94066
Covered Property (1)
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Patent: 8,012,976 →
Application: 12/510,096 →
Publication: US 2010/0035883
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 3, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025765/0990 →
Security Interest Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →
Assignment of Assignor's Interest Mar 30, 2016
From: BIOMARIN PHARMACEUTICAL INC.
To: MEDIVATION, INC.
Reel/Frame 038137/0906 →
Assignment of Assignor's Interest Mar 30, 2016
From: MEDIVATION, INC.
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 038138/0043 →
Release of Security Interest Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION, INC.
Reel/Frame 039873/0219 →
Certificates of Formation and Conversion Mar 12, 2018
From: MEDIVATION TECHNOLOGIES, INC.
To: MEDIVATION TECHNOLOGIES LLC
Reel/Frame 045568/0925 →
Assignee Address Correction Mar 20, 2023
From: MEDIVATION TECHNOLOGIES LLC
To: MEDIVATION TECHNOLOGIES LLC
Reel/Frame 063117/0642 →